Zhengye Biotechnology Holding (ZYBT) Total Current Liabilities (2023 - 2024)
Zhengye Biotechnology Holding (ZYBT) has disclosed Total Current Liabilities for 2 consecutive years, with $18.9 million as the latest value for Q4 2024.
- Quarterly Total Current Liabilities fell 9.32% to $18.9 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $18.9 million through Dec 2024, down 9.32% year-over-year, with the annual reading at $18.6 million for FY2024, 12.42% down from the prior year.
- Total Current Liabilities for Q4 2024 was $18.9 million at Zhengye Biotechnology Holding, down from $20.9 million in the prior quarter.
- The five-year high for Total Current Liabilities was $20.9 million in Q4 2023, with the low at $18.9 million in Q4 2024.